Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtrer
1.
Am J Transplant ; 14(1): 96-101, 2014 Jan.
Article de Anglais | MEDLINE | ID: mdl-24369026

RÉSUMÉ

Visceral leishmaniasis is an uncommon disease in transplant recipients; however, if left untreated, the mortality can be high. If an organ donor or recipient is known to be an asymptomatic Leishmania spp. carrier,monitoring is advised. This study proposes to assess the prevalence of asymptomatic Leishmania spp.infection in liver transplant donors and recipients from an endemic area. A total of 50 liver recipients and 17 liver donors were evaluated by direct parasite search, indirect fluorescent antibody test (IFAT), anti-Leishmania rK39 rapid test and Leishmania spp.DNA detection by polymerase chain reaction (PCR).Leishmania spp. amastigotes were not observed in liver or spleen tissues. Of the 67 serum samples, IFAT was reactive in 1.5% and indeterminate for 17.9%, and the anti-Leishmania rK39 rapid test was negative for all samples. The PCR test was positive for 7.5%, 8.9%, and 5.9% of blood, liver and spleen samples, respectively(accounting for 23.5% of the donors and 8% of the recipients). Leishmania infantum-specific PCR confirmed all positive samples. In conclusion, a high prevalence of asymptomatic L. infantum was observed in donors and recipients from an endemic area, and PCR was the most sensitive method for screening these individuals.


Sujet(s)
Leishmaniose viscérale/épidémiologie , Transplantation hépatique/effets indésirables , Adolescent , Adulte , Sujet âgé , Brésil/épidémiologie , Enfant , Enfant d'âge préscolaire , Études transversales , ADN des protozoaires/analyse , Femelle , Technique d'immunofluorescence , Humains , Leishmania/génétique , Leishmania infantum/immunologie , Leishmaniose viscérale/diagnostic , Mâle , Adulte d'âge moyen , Réaction de polymérisation en chaîne , Prévalence , Études prospectives , Donneurs de tissus
2.
Transplant Proc ; 45(1): 297-300, 2013.
Article de Anglais | MEDLINE | ID: mdl-23375318

RÉSUMÉ

The Model for End-Stage Liver Disease (MELD), which predicts mortality on the waiting list before liver transplantation, has changed organ allocation criteria to prioritize severely ill patients. The aim of this study was to investigate the impact of the new criteria on the incidence of Healthcare Associated Infections (HAI) and patient survival after liver transplantation. This retrospective cohort included liver transplant recipients from 2005 to 2007. Infection notification followed the recommended criteria of the National Healthcare Safety Network (NHSN). Statistical analysis was performed using the Statistical Package for the Social Sciences. Of 142 patients, 67 (47.2%) underwent transplantation before June 2006. There were no differences between the 2 periods considering patient gender, diagnosis, age, length of hospitalization, and mean time to first infection occurrence. However, the length of intensive care unit (ICU) hospitalization (P = .006) and central venous catheter (CVC) use (P = .025) were higher in the first period of the study. Comparison of time until first systemic infection before and after changes in allocation criteria showed no significant difference (log-rank = 0.06; P = .81). There was a trend toward greater lethality during the second period of the study (P = .09). There was no difference in time to death between the 2 periods (log-rank = 0.9; P = .76). However, when comparing time to death of all patients with systemic infection versus those without this event, patients without infection showed a higher mortality rate (log-rank = 15.7; P < .001).


Sujet(s)
Maladie du foie en phase terminale/anatomopathologie , Maladie du foie en phase terminale/thérapie , Défaillance hépatique/chirurgie , Transplantation hépatique/méthodes , Acquisition d'organes et de tissus/méthodes , Listes d'attente , Adolescent , Adulte , Sujet âgé , Algorithmes , Brésil , Études de cohortes , Maladies transmissibles/complications , Maladies transmissibles/thérapie , Femelle , Humains , Mâle , Adulte d'âge moyen , Modèles statistiques , Facteurs temps , Résultat thérapeutique , Jeune adulte
3.
Trop Med Int Health ; 16(9): 1134-42, 2011 Sep.
Article de Anglais | MEDLINE | ID: mdl-21692958

RÉSUMÉ

OBJECTIVE: To evaluate the frequency and clinical features of endemic and other opportunistic infections in liver or kidney transplant recipients in four transplant centres in different geographical areas of Brazil. METHODS: Retrospective analysis of medical and laboratory records of four transplant centres on endemic and other opportunistic infections in liver or kidney transplant recipients. Analyses were performed with spss statistical software. RESULTS: From 2001 to 2006, 1046 kidney and 708 liver transplants were registered in all centres. The average age was 42 years. Among 82 (4.7%) cases with infections, the most frequent was tuberculosis (2.0%), followed by systemic protozoal infections (0.7%), toxoplasmosis (0.4%) and visceral leishmaniasis (0.3%). Systemic fungal infections occurred in 0.6%, of which 0.4% were cryptococcosis and 0.2% were histoplasmosis. Dengue was the only systemic viral infection and was registered in two cases (0.1%), of which one was classified as the classic form and the other as dengue haemorrhagic fever. Nocardiosis was described in one case (0.05%). The infectious agents most frequently associated with diarrhoea were Blastocystis sp., Schistosoma mansoni and Strongyloides stercoralis. CONCLUSIONS: Opportunistic Infections in transplant patients have a wide spectrum and may vary from asymptomatic to severe infections with high mortality. A better understanding of the epidemiology of endemic pathogens and clinical manifestations can contribute to the establishment of an early diagnosis as well as correct treatment aimed at decreasing morbidity and mortality.


Sujet(s)
Maladies endémiques/statistiques et données numériques , Sujet immunodéprimé , Transplantation rénale/effets indésirables , Transplantation hépatique/effets indésirables , Infections opportunistes/épidémiologie , Transplantation d'organe/effets indésirables , Adulte , Brésil/épidémiologie , Maladies endémiques/prévention et contrôle , Femelle , Humains , Immunosuppresseurs/usage thérapeutique , Transplantation rénale/mortalité , Transplantation hépatique/mortalité , Mâle , Transplantation d'organe/mortalité , Complications postopératoires/épidémiologie , Études rétrospectives
5.
Transpl Infect Dis ; 11(2): 132-6, 2009 Apr.
Article de Anglais | MEDLINE | ID: mdl-18983416

RÉSUMÉ

Strongyloides stercoralis is an intestinal nematode that causes human infections and whose life cycle has special features, including autoinfection. Strongyloides infection may be asymptomatic for years, owing to a low parasite load. During immunosuppressive therapy, however, if cellular immunity is depressed, autoinfection can occur at a higher rate, resulting in hyperinfection syndrome. In this specific circumstance, it can become a fatal illness. We describe a case of hyperinfection syndrome in a liver transplant recipient and also review the literature.


Sujet(s)
Immunosuppresseurs/effets indésirables , Transplantation hépatique/effets indésirables , Complications postopératoires/parasitologie , Strongyloides stercoralis , Strongyloïdose/étiologie , Surinfection/étiologie , Adulte , Animaux , Anthelminthiques/usage thérapeutique , Issue fatale , Rejet du greffon/prévention et contrôle , Humains , Immunosuppresseurs/usage thérapeutique , Mâle , Complications postopératoires/diagnostic , Complications postopératoires/traitement médicamenteux , Récidive , Strongyloïdose/diagnostic , Strongyloïdose/traitement médicamenteux , Surinfection/diagnostic , Surinfection/traitement médicamenteux
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE